Introduction to Drug Development
Overview of drug development from discovery to clinical trials, including history, preclinical/clinical activities, and applications to neurological disease drug development.
Summary
Recent recorded grades — Fall 2023: 3.97 GPA, 100.0% A/AB (n=54 letter grades); Fall 2024: 3.90 GPA, 93.5% A/AB (n=31 letter grades); Fall 2025: 3.96 GPA, 100.0% A/AB (n=51 letter grades).
What you’ll be able to do
Provide historical context for the modern drug discovery and development process.
Describe the high-level goals and activities that take place during discovery, preclinical development, and clinical development and the different functional areas that perform this work.
Apply the knowledge learned throughout the course to address specific drug development scenarios.
Propose novel strategies to address current drug development challenges.
Evaluate scientific literature and regulatory documents to find important information about specific drugs.
Source: UW Guide
Grade history
↗All recorded terms · compare terms & instructors
Prerequisites
Course mapDeclared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation
- Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation
“Used by” includes alternatives; linked courses may have other requirements. This is a best-effort interpretation; check the catalog requirements above.
Prerequisite text tree
- Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation
Professors
Spring 2027No instructors recorded for this selection.
Historical instructors & teaching patterns
Recorded history may be incomplete and does not establish a future schedule.
Calendar & sections
Spring 2027Schedule loads here as you scroll.
| Section | Mode | Enrolled / capacity | Waitlist |
|---|
Times are Central. Select a meeting for details; export includes recorded dates for the selected sections.
Meeting source records
No records available.
Student experience
the class
Recent recorded grades — Fall 2023: 3.97 GPA, 100.0% A/AB (n=54 letter grades); Fall 2024: 3.90 GPA, 93.5% A/AB (n=31 letter grades); Fall 2025: 3.96 GPA, 100.0% A/AB (n=51 letter grades).
difficulty & workload
No workload feedback recorded.
Topics
- History of drug development and overview of discovery, preclinical, and clinical activities.
- Real-world drug development scenarios and challenges in treating neurological diseases.
Skills
- Applying drug development knowledge to real-world scenarios and evaluating scientific literature and regulatory documents.
Grades
Latest available · Fall 2025— not enough history to project Spring 2027.
Grade distribution · % of letter grades
Grades over time
Through Fall 2025
More grade details Grade mix, volume & source data
Sources & history
Catalog & offerings
Descriptions, prerequisites, and recorded course offerings.
Catalog observation history
Observations at scan time; dates do not imply when a catalog change took effect.
Selected offering source records
No offering records for the selected term.
Raw records
[]
Student reviews
Original comments behind the course and instructor summaries.
Read original reviews
No records available.
Grade history
Recorded grade distributions by term, section, and instructor.
Explore recorded gradesRecorded 2026-10-14
Model outputs & technical records
LLM outputs across runs
Full model traces
Recorded model configuration, reasoning, and tool conversations.
Model & dataset provenance
{
"model": "Qwen/Qwen3.8-27B",
"model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
"task_version": "17",
"output_id": "5b700a251ef5e971fe100dcebba11ff2de882d68ecbdec0bc0feb54cdfb96395",
"requirements_status": "valid",
"dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
"observed_at": "2026-10-14 17:50:09.728220+00:00"
}